The Changes of Thyroid Function after Subtotal Thyroidectomy in Diffuse Toxic Goiter(Graves' Disease)

미만성 갑상선중독증(그레이브씨병)의 갑상선 아전절제술 후 갑상선 기능의 변화에 대한 연구

  • Song Eun-Young (Department of Surgery, Inje University Pusan Paik Hospital) ;
  • Kim Sung-Bae (Department of Surgery, Inje University Pusan Paik Hospital) ;
  • Kim Sang-Hyo (Department of Surgery, Inje University Pusan Paik Hospital)
  • 송은영 (인제대학교 의과대학 부산백병원 외과학교실) ;
  • 김성배 (인제대학교 의과대학 부산백병원 외과학교실) ;
  • 김상효 (인제대학교 의과대학 부산백병원 외과학교실)
  • Published : 2002.05.01

Abstract

Objectives: Three classic treatment modalities have been used to treat Graves' disease: antithyroid medication, radioiodine ablation, and subtotal thyroidectomy. Postoperative thyroid functions were studied in patients with Graves' disease treated by subtotal thyroidectomy to evaluate the superiority of surgical treatment. Materials and Methods: One hundred fourty patients of Graves' disease were analysed retrospectively in follow-up for more than three years following subtotal thyroidectomy. Postoperative serum levels of $T_3,\;T_4, TSH, TSH-R Ab, free $T_4$, were evaluated to watch hypo- or hyperthyroidsm. Results: In the evaluation of preop- and postoperative thyroid function after three years of subtotal thyroidectomy, $T_3$ was changed from $464.10{\pm}196.16ng/dl$ to $140.41{\pm}76.56ng/dl$ in mean value, $T_4$ was changed from $20.76{\pm}7.98{\mu}g/dl$ to $9.54{\pm}4.02{\mu}g/dl$, $TSHT_3$ was changed from $0.55{\pm}4.42{\mu}u/ml$ to $4.96{\pm}7.20{\mu}u/ml$, TSH-R Ab was changed from $41.6{\pm}28.27%$ to $28.7{\pm}28.79%$ and free $T_4$ was changed from $4.45{\pm}2.33ng/dl$ to $1.44{\pm}0.69ng/dl$ in mean value. Euthyroidism was noted in 118 patients(84.3%), overt hyperthyroidism in 6 patiens(4.3%), latent hyperthyroidism in 8 patients(5.7%), overt hypothyroidism in 2 patint(1.4%), and latent hypothyroidism in 6 patients(4.3%). Of surgical complications, permanant hypoparathyroidism was found in one patient, recurrent laryngeal nerve injury in two patients, postoprative bleeding with reoperation in two patients, and death in one patient. Conclusion: The thyroid function after subtotal thyroidectomy in diffuse toxic goiter is normal level (euthyroidism) in 84.3% and low recurrence rate of hyperthyroidism is showed with rare surgical complication. Therefore, subtotal thyroidectomy in diffuse toxic goiter is more effective and safe than RI or longterm ATD treatment, if the operation is performed by skillful surgeon.

Keywords

References

  1. Bringmann JM, van Leeuwen BL, Hennemann G, Beckett GJ, Toft AD : Outcome of treatment of hyperthyroidism. J EndocrinolInvest. 1999 ; 22 (4) : 250-256
  2. Pauwels EK, Smith JW, Slats A, Bourguignon M, Overbeek F : Health effects of therapeutic use of 131I in hyperthyroidism. J Nucl Med. 2000 ; 44(4) : 333-339
  3. Okamoto T, Iihara M, Obara T : Management of hyperthyroidism due to Graves' and nodular disease. World J Surg. 2000 ; 24 (8) : 957-961 https://doi.org/10.1007/s002680010167
  4. Werga-Kjellman P, Zedenius J, Tallstedt L, Traisk F, Lundell G, Wallin G : Surgical treatment of hyperthyroidism. Thyroid. 2001 ; 11 (2) : 187-192 https://doi.org/10.1089/105072501300042947
  5. Kim JP : Thyoid. Textbook of modem surgery. 2nd edition. Seoul : Ilchokak. 1995 : 621-642
  6. Yoko Mori, Naoya Matoba, Shunji Miura, Nobumitsu Sakai, Yukio Taira : Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease. World J Surg. 1992 ; 16 : 647-653 https://doi.org/10.1007/BF02067345
  7. Yoshifumi Abe, Haruhiro Sato, Masako Noguchi, et al : Effect of subtotal thyroidectomy on natural history of ophthalmopathy in Graves' disease. World J Surg. 1998 ; 22 : 714-717 https://doi.org/10.1007/s002689900458
  8. Winsa b, Rastad J, Akerstrm G, Johansson H, Westermark K, Karlsson FA : Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalopathy. Eur J Endocrinol. 1995 ; 132 (4) : 406-412 https://doi.org/10.1530/eje.0.1320406
  9. Takahiro Okamoto, Yoshihide Fujimoto, Takao Obara, Yukio Ito, Motohiko Aiba : Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease. World J Surg. 1992 ; 16 : 690-696 https://doi.org/10.1007/BF02067359
  10. Kiminori Sugino, Koichi Ito, Osamu Ozaki, et al : Postoperative changes in thyrotropin-binding inhibitory immunoglobuline level in patients with Graves' disease : is subtotal thyroidectomy a suitable therapeutic option for patients ofchildbearing age with Graves' disease? World J Surg. 1999 ; 23 : 727-731 https://doi.org/10.1007/PL00012377
  11. Hwang DJ, Lee SD, Nam SJ, Oh YR, Chung JR, Yang JR : Surgical treatment ofGraves' disease. J Korean Surg Soc. 2000 ; 58 (4) : 494-501
  12. Sheng WH, Hung CC, Chen YC, et al : Antithyroid drug-induced agranulocytosis complicated by life-threatening infection. QJM. 1999 ; 92 (8) : 455-461 https://doi.org/10.1093/qjmed/92.8.455
  13. Solomon DH : Treatment of Graves' disease. In The Thyroid, 5th edition, SH Ingbar; LE Braverman, editors, Philadelphia, Lippincott. 1986 : 987-1014
  14. Han SH, Ko KS, Rhee BD, et al : Total thyroidectomy in Graves'disease. J Korean Surg Soc. 1999 ; 57(1) : 22-26
  15. Melliere D, Etienne G, Becquemin JP : Operationfor hyperthyroidism : methods and rationale. Am J Surg. 1988 ; 155 : 395-399 https://doi.org/10.1016/S0002-9610(88)80098-9
  16. Cusick EL, Krukowski ZH, Metheson NA : Outcome ofsurgery for Graves' disease: re-examined. Br J Surg. 1987 ; 74 : 780-783 https://doi.org/10.1002/bjs.1800740909
  17. Okamoto T, Iihara M, Obera T : Management of hyperthyroidism due to Graves' and nodular diseases. World J Surg. 2000 ; 24 (8) : 957-961 https://doi.org/10.1007/s002680010167
  18. Linos DA, Karakitsos D, Papademmetriou J : Should the primary treatment of hyperthyroidism be surgical? Eur J Surg. 1997 ; 163 :651-657